Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

CONNECTing Head and Neck Caregivers to Supportive Care Resources (CONNECT-HNC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03875885
Recruitment Status : Not yet recruiting
First Posted : March 15, 2019
Last Update Posted : March 15, 2019
Sponsor:
Collaborator:
National Center for Advancing Translational Science (NCATS)
Information provided by (Responsible Party):
Wake Forest University Health Sciences

Brief Summary:
The purpose of this research is to determine feasibility and acceptability of randomized pilot trial to evaluate a technology-based intervention (CONNECT) to empower and educate caregivers about the benefits of supportive care resources, identify their unmet needs, and connect them with resources.

Condition or disease Intervention/treatment Phase
Head and Neck Cancer Behavioral: CONNECT Behavioral: CONTROL Not Applicable

Detailed Description:
The registration is for Objective two and three that refers to the clinical trial. The investigators will determine their ability to recruit caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center to a study that uses a technology-based intervention, CONNECT, which may increase head and neck cancer caregivers' knowledge about the benefits of supportive care resources, identify their unmet needs, and connect them with supportive care resources. In this study the investigators also want to look at their ability to recruit a control group of caregivers, that is, caregivers of patients with head and neck cancer being treated at Wake Forest Baptist Comprehensive Cancer Center that will receive a list of supportive care resources. Control groups are used in research to see if the intervention being studied really does have an effect. In addition, the investigators will determine whether or not the intervention has led to improvements in caregivers' use of supportive care resources, quality of care, and overall quality of life.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 40 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Other
Official Title: CONNECTing Caregivers to Supportive Services (CONNECT): A Technology-Based Intervention to Connect Cancer Caregivers With Supportive Care Resources
Estimated Study Start Date : May 31, 2019
Estimated Primary Completion Date : June 30, 2020
Estimated Study Completion Date : March 30, 2021

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
CONNECT arm
A web-based intervention (CONNECT) to empower and connect caregivers of newly diagnosed cancer patients to supportive care resources A randomized pilot study will be conducted to assess feasibility and acceptability and obtain data on caregiver and patient outcomes. CONNECT e-tool, re-education and optional referral (2 weeks post CONNECT e-tool). Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
Behavioral: CONNECT
A novel web-based intervention with input from an advisory panel of cancer caregivers, oncology providers, and psychosocial oncology professionals empowering caregivers with needs to seek services by providing education about the benefits of supportive care resources, systematically identifying their unmet needs, and connecting them with tailored supportive care resources.

CONTROL arm
Baseline, one month post randomization data collection, three months post randomization data collection, quantitative and qualitative measures.
Behavioral: CONTROL
This group will receive a generic resource list.




Primary Outcome Measures :
  1. Proportion of Caregivers Who Agree to Participate [ Time Frame: 9 months ]
    Number of caregivers who agreed to participate divided by the number of months of recruitment

  2. Proportion of Eligible Participants [ Time Frame: 9 months ]
    Proportion of eligible participants who agreed to participate

  3. Proportion of Retention of Participants [ Time Frame: 9 months ]
    Number of participants who completed the T2 assessment divided by the number who agreed to participate

  4. Acceptability [ Time Frame: 9 months ]
    Survey developed for study to assess how much caregivers liked different aspects of CONNECT; and a ~30min (approximately) qualitative interview to further explore acceptability. (Appendices I, J, and K)


Secondary Outcome Measures :
  1. Supportive Care Utilization [ Time Frame: Over 3 months ]
    Adapted version of the 28-item Consumer-Based Cancer Care Value Index- Services and Resources instrument assessing use of services to meet multidimensional supportive needs. Intervention caregivers will also self-report service use by completing an auto-generated REDCap survey to query about utilization of the specific resources that each caregiver expressed interest in accessing.

  2. FAMCARE Questionnaire (Caregiver) [ Time Frame: Over 3 months ]
    A 20-item instrument with 4 subscales to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control. Participants will answer questions to indicate how satisfied they are with care family member has received. (Subscales = (S) satisfied, (U) undecided, (D) dissatisfied or (VD) very disatisfied

  3. Caregiver Reaction Assessment [ Time Frame: Over 3 months ]
    Caregiver Reaction Assessment - 21-item instrument assessing positive and negative aspects of caregiving (esteem, lack of family support, finances, schedule, and health). The CRA has been tested in cancer caregivers; demonstrated validity and reliability. Each item is rated on a 1 to 4 scale. 1 (not at all) 2 (somewhat) 3 (quite a bit) 4 (completely)

  4. PROMIS Emotional Distress-Anxiety-Short Form 8a [ Time Frame: Over 3 months ]
    An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations. Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of anxiety.

  5. PROMIS Emotional Distress- Depression-Short Form 8a [ Time Frame: Over 3 months ]
    An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of interest, meaning, and purpose. Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.


Other Outcome Measures:
  1. SF-12 Patient Measures - Physical Well-being [ Time Frame: Over 3 months ]
    A 12-item instrument measuring physical and mental well-being, though our analyses will focus on physical well-being; widely used in oncology populations. Physical and Mental Health Composite Scores (PCS & MCS) are computed using the scores of twelve questions and range from 0 to 100, where a zero score indicates the lowest level of health measured by the scales and 100 indicates the highest level of health.

  2. Unplanned Healthcare Utilization Survey [ Time Frame: Over 3 months ]
    Unplanned healthcare utilization survey will be calculated using a one item continuous score. The survey will capture patient self-reported unplanned healthcare utilization (number of unplanned visits to the emergency room, urgent care, or healthcare provider) from time points of baseline to end of treatment.

  3. FAMCARE Questionnaire (Patient) [ Time Frame: Over 3 months ]
    A 20-item instrument with 4 subscales to assess family caregiver satisfaction with information giving, availability of care, physical patient care, and symptom control. Participants will answer questions to indicate how satisfied they are with care family member has received. (Subscales = (S) satisfied, (U) undecided, (D) dissatisfied or (VD) very dissatisfied

  4. PROMIS Emotional Distress-Anxiety-Short Form 8a for Patients [ Time Frame: Over 3 months ]
    An 8-item instrument that assesses fear, anxious misery, hyperarousal, and somatic symptoms related to arousal; widely used in oncology populations

  5. PROMIS Emotional Distress- Depression-Short Form 8a for Patients [ Time Frame: Over 3 months ]
    An 8-item instrument that assesses sadness, guilt, self-criticism, worthlessness, loneliness, interpersonal alienation, as well as loss of interest, meaning, and purpose.Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression. Each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of anxiety.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Have a history (current or past [within prior 18 months]) of providing unpaid care for an adult (>18 years of age) family member or significant other with AJCC stage I-IV HNC (squamous cell carcinoma of the upper aerodigestive tract).
  • Eligible caregivers for Objectives Two and Three include those who are:
  • Providing the majority of the informal (unpaid) care for a patient meeting the below criteria, and
  • Greater than or equal to 18 years of age
  • Eligible patients for Objectives Two and Three include those who:
  • Have new or recurrent AJCC stage I-IV HNC,
  • Are receiving cancer treatment or awaiting planned treatment initiation, and
  • Greater than or equal to 18 years of age

Exclusion Criteria:

  • Participants will be excluded if they are not able to read/understand English, or
  • If they have significant hearing impairment that would hinder participation

Caregivers for Objective Two and Three will be excluded if:

  • They have a current cancer diagnosis, or
  • Cannot read/communicate in English
  • Patients for Objectives Two and Three will be excluded if they:
  • Cannot read/communicate in English

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03875885


Contacts
Layout table for location contacts
Contact: Chandylen Nightingale, PhD, MPH 336-713-1432 cnightin@wakehealth.edu

Sponsors and Collaborators
Wake Forest University Health Sciences
National Center for Advancing Translational Science (NCATS)
Investigators
Layout table for investigator information
Principal Investigator: Chandylen Nightingale, PhD, MPH Wake Forest University Health Sciences

Layout table for additonal information
Responsible Party: Wake Forest University Health Sciences
ClinicalTrials.gov Identifier: NCT03875885     History of Changes
Other Study ID Numbers: IRB00056635
5KL2TR001421-04 ( U.S. NIH Grant/Contract )
6459 ( Other Identifier: WF Wiser number )
First Posted: March 15, 2019    Key Record Dates
Last Update Posted: March 15, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Wake Forest University Health Sciences:
Head and Neck Cancer Caregivers

Additional relevant MeSH terms:
Layout table for MeSH terms
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms